Chiyuan Ma

8PUBLICATIONS
2CO-AUTHORS
Environmental biotechnology diagnostics (incl. biosensors)Epidemiological modellingPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 05, 2024
Endocrine Outcomes and Associated Predictive Factors for Somatotrophin Pituitary Adenoma after Endoscopic Endonasal Transsphenoidal Surgery: 10 Years of Experience in a Single Institute.

Yuanming Geng, Qian Dong, Zixiang Cong

|Jul 31, 2023
Predictors and dynamic online nomogram for postoperative delayed hyponatremia after endoscopic transsphenoidal surgery for pituitary adenomas: a single-center, retrospective, observational cohort study with external validation.

Xiangming Cai, An Zhang, Peng Zhao

|Oct 13, 2022
N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas.

Feng Yuan, Yingshuai Wang, Xiangming Cai

|Apr 09, 2022
Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.

Xiangming Cai, Junhao Zhu, Jin Yang

|Feb 19, 2022
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.

Feng Yuan, Yingshuai Wang, Chiyuan Ma

|Nov 25, 2021
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.

Junhao Zhu, Chao Tang, Zixiang Cong

Pageof 2

Frequent Collaborators

1 joint publications

Feng Yuan

1 joint publications

Jin Yang